Cimarron Healthcare Capital LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Cimarron Healthcare Capital LLC
CRD #282387
SEC #801-126250
CIK #
AUM 532.7 M (2026-03-26)
Employees 7 (100% Investors, 0% Brokers)
Phone801-849-9293
Address6440 S Wasatch Blvd
Salt Lake City, UT 84121
Source [IAPD] [Website] [LinkedIn]
Total AUM ($M)
60048036024012002010201520212027
Type Form D Funds Date Sold AUM
PE PV365 Co-Invest LP [2024-03-27] 27.1 M
Filed 2023-04-21 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Cimarron Continuation Fund LP [2022-03-31] 178.1 M
Filed 2021-03-19 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $1,130,000 · Revenue Decline to Disclose
PE Cimarron Healthcare Capital Fund II-A LP 2022-03-31 2.4 M
PE Cimarron Healthcare Capital Fund II-B LP [2022-03-31] 118.7 M 7.9 M
Filed 2023-02-06 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $3,500,000 · Revenue Decline to Disclose
PE Cimarron Healthcare Capital Fund II LP [2022-03-31] 118.7 M 141.6 M
Filed 2023-02-06 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $3,500,000 · Revenue Decline to Disclose
PE Olympus Ascent Investors LLC [2021-03-29] 11.5 M 16.5 M
Offered $11,495,832 · Filed 2020-03-13 (D) · Exemption 506(b), 3(c)(1), 3(c) · Minimum $63,750 · Duration One year or less · Revenue Decline to Disclose
PE Cimarron Healtchare Investments II LP [2017-03-27] 1.0 M 1.6 M
Offered $2,000,000 · Filed 2015-07-06 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $1,000,000 · Duration One year or less · Revenue Decline to Disclose
PE Cimarron Healthcare Investments I LP [2016-01-04] 4.0 M 150.9 M
Offered $50,000,000 · Filed 2015-07-06 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $46,000,000 · Duration One year or less · Revenue Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 7 532.7
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 8 532.7
By Discretionary
Discretionary 8 532.7
Non-Discretionary 0 0.0
Total 8 532.7
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 532.7
Total 8 532.7
Form D Directors Role # Filings # Firms 2011 - 2026
Robert Adelson Executive Officer 25 5
James Nadauld Executive Officer 12 2
Clay Andrus Executive Officer 1 1
Olympus Ascent GP LLC Director 1 1
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesPrivate Equity
Comparable Firms State AUM
K Fund Capital Management LLC
CA 539.3 M
BP Capital Energy Advisors LLC
TX 537.2 M
Juniper Capital Advisors LP
TX 535.4 M
Sky Island Capital LP
TX 533.5 M
New Silk Route Advisors LP
NY 531.5 M
Cap91 Partners Management LLC
VA 531.0 M
Securitize Capital LLC
FL 530.2 M
A-Street Management LP
530.0 M
Archean Capital Partners II LLC
PA 527.8 M
One Bow River Advisers LLC
CO 525.9 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com